📉 Emcure Pharma Slips 3% as Bain Capital Offloads Stake in Block Deal

Shares of Emcure Pharmaceuticals declined by 3% on Tuesday following a significant block deal on the exchanges. The transaction involved approximately 40.6 lakh shares, or about 2.4 percent of the company's equity, changing hands. The sell-off is strongly linked to Bain Capital’s BC Investments, which was expected to divest up to 2% of its holding. The deal size was estimated at up to Rs 493 crore, based on an indicative floor price of Rs 1,296.51 per share—a discount of about 7% to Monday's closing price. Prior to the sale, BC Asia held a 6.3% stake in Emcure Pharma as of the end of Q2 2025.